Indomira is a U.S. phytopharmaceutical company dedicated to establishing new standards for CBD and Hemp. As a vertically-integrated operation, we are developing clinically-proven medicines that enhance everyday health, provide preventive strategies, and address modern conditions.
As prohibition gives way to changing sentiment, an unprecedented wave of research around the world is validating the efficacy of Hemp and Cannabis, both as a medical treatment and a wellness therapy. This research is providing hope, awareness, and solutions for managing conditions such as cancer, chronic pain, epilepsy, and multiple sclerosis.
Indomira’s contribution to the development of the scientific framework for safe and effective use, education for healthcare professionals, and the evolution of public awareness is at the heart of our mission. Through research, education, and knowledge-sharing, we’re inspiring new thinking and informed decisions about CBD and health.
We integrate principles from traditional and modern medicine, taking into account the whole human and the whole plant, while being firmly grounded in research, evidence, and clinical experience.
As a vertically-integrated company, we maintain uncompromising standards in our agricultural operations, our production processes, and our research methodologies.
As a direct result of our philosophy and our approach, we produce the highest-grade, standardized Cannabis and botanical medicines to support health and address specific conditions.
The Conversation around CBD is Evolving
We are shaping that evolution through innovative, physician-formulated therapies and science-based outreach and advocacy. Here’s where we are, where we’ve been, and where we’re going.
Laying the foundationWe established Indomira’s U.S. based farm, regulation-compliant lab, and state-of-the-art research facility in Southern Oregon’s Rogue Valley. Our formulation team began development of proprietary CBD products based on clinical experience with over 3,000 patients.
Going to market
The changing marketplace and regulatory landscape brought a new outlook on medical Cannabis and CBD products. We launched our first CBD brand — Green Earth Medicinals. Customer response to our oral and topical formulas has been overwhelmingly positive.
Working closely with regulatory authorities, we continue to draw on our clinical experience and patient outcomes to shape more relevant therapies according to the highest standards for safe, effective CBD products.
We have expanded our product offerings in the United States, and worldwide, and continue our clinical trials for pain management, cancer, and other conditions. We aim to strengthen our efforts — and accelerate regulatory change — by partnering with research professionals who share our mission and vision.
A New Chapter
We are pleased to offer our services to strategic partners in the region for co-manufacturing, quality control, and consulting. We continue to develop wellness and condition-specific therapies with GxPm GMP and ISO 9001 compliance, and the highest quality natural ingredients and standards.
CBD is Medicine
The clinical utility of Hemp and Cannabis has a rich legacy of more than 3,000 years. Despite the misguided “war on drugs” initiated by the United States, there is a global reawakening to the healing potential of CBD that grows by the day. This movement is inspiring individuals, medical professionals, scientists, and policymakers to imagine new solutions for the role of Cannabinoids in medicine and society.
For All Of Us
Everyone has a right to safe, sustainable, and effective solutions that support their health and lifestyle. Clinical evidence overwhelmingly supports CBD as an effective treatment for medical conditions like epilepsy and chronic pain. It’s also become increasingly popular in wellness practices as a part of fitness and culinary plans.
For Healthcare Providers
Clinical thinking is part of Indomira’s DNA. We educate and partner with healthcare providers looking to better understand the endocannabinoid system and plant science — as well as condition-specific applications, routes of administration, dosages, and cultivars. We believe that as Cannabis science matures, a new era in empowered healthcare will emerge.
For Regulators and Policymakers
Science, safety, and effective governance must inform the decisions governments make about regulating plant-based medicines. We work with advocates and policymakers alike to create an open, clear, and compassionate dialogue among scientists, regulators, manufacturers, and the public.
We Are Here For You
Testing Facilitation (External)
Testing Services (In-house R&D)
Research and Development
White Label Manufacturing:
cGMP and ISO 9000 Compliance
Packaging and Ingredient Sourcing
At our Southern Oregon location, we provide a wide range of services and products to meet your custom CBD manufacturing needs. Our state of the art processing, extraction and formulation facilities meet or exceed standards. Please use the contact form below to ask questions or to request more information.
Advanced Cannabis Phytopharmaceuticals
© 2020 Indomira. All Rights Reserved.